Acadia Healthcare (ACHC) AI Stock Analysis

• Market Cap: $2.01B
• Dividend Yield: N/A
• Average Volume (3M): 3.09M
• Price to Earnings (P/E): 14.4
• Beta (1Y): 0.77
• Revenue Growth: 5.64%
• EPS Growth: N/A
• Country: US
• Employees: 25,500
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.83
• Shares Outstanding: 92,346,596
• 10 Day Avg. Volume: 2,195,178
• 30 Day Avg. Volume: 3,085,986
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 2.21
• Enterprise Value/Revenue: 1.38
• Enterprise Value/Gross Profit: 1.70
• Enterprise Value/Ebitda: 8.93
• 1Y Price Target: $28.08
• Price Target Upside: 28.81% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12

• Rating: 68 Neutral
• Price Target: $26.00 ▲(19.27% Upside)

Acadia Healthcare's overall stock score is driven by strong financial performance in terms of revenue growth and gross profit margins, despite challenges in profitability and cash flow conversion. Technical indicators suggest a positive short to mid-term trend, while valuation remains moderate. The earnings call highlighted significant growth and expansion, though some operational challenges persist.

Positive Factors

Revenue Growth

Acadia's consistent revenue growth, driven by increased patient volume and service expansion, indicates strong market demand and effective business strategies.

Expansion and Development

The addition of new beds and facilities enhances Acadia's capacity to serve more patients, supporting long-term growth and market presence.

Favorable Labor Trends

Improved labor conditions and cost management enhance operational efficiency, contributing to sustained profitability and competitive advantage.

Negative Factors

Increased Leverage

Higher leverage may limit financial flexibility and increase risk, potentially impacting Acadia's ability to invest in growth opportunities.

Net Profit Margin Decline

A declining net profit margin suggests challenges in cost control and profitability, which could affect long-term financial health if not addressed.

Medicaid Volume Pressures

Pressure from Medicaid volumes could impact revenue stability, as changes in payer mix and utilization patterns affect reimbursement levels.

Acadia Healthcare Business Overview & Revenue Model

Company Description

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.

How the Company Makes Money

Acadia Healthcare generates revenue primarily through the provision of healthcare services, which are reimbursed by a variety of payers including private insurance companies, government programs such as Medicare and Medicaid, and self-pay patients. The company operates on a fee-for-service model, where revenue is derived from the number of patients treated and the services rendered, including inpatient stays and outpatient visits. Additionally, Acadia benefits from contractual agreements with insurance providers that facilitate patient access to its services. The company also focuses on expanding its network through acquisitions and partnerships, enhancing its capability to serve a broader patient base and increase revenue streams.

Acadia Healthcare Financial Statement Overview

Summary

Acadia Healthcare shows robust revenue growth and strong gross profit margins, but faces challenges in maintaining net profitability and operational efficiency. The balance sheet indicates increased leverage, posing potential risks. Cash flow generation is mixed, with strong operating cash flow but weak free cash flow.

Income Statement

Acadia Healthcare shows a consistent revenue growth trend, with a TTM revenue growth rate of 2.32%. The gross profit margin has improved significantly to 81.24% in the TTM, indicating strong cost management. However, the net profit margin has decreased to 4.31% from 8.10% in the previous year, reflecting challenges in maintaining profitability. The EBIT and EBITDA margins have also declined, suggesting pressure on operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has increased to 0.78 in the TTM, indicating a higher reliance on debt financing. Return on equity has decreased to 4.56%, reflecting reduced profitability. The equity ratio remains stable, suggesting a balanced asset structure. Overall, the balance sheet shows moderate leverage with potential risks from increased debt levels.

Cash Flow

Operating cash flow has improved significantly in the TTM, but free cash flow remains low, with a negative growth rate of -136.34%. The operating cash flow to net income ratio is strong at 0.81, indicating good cash generation relative to earnings. However, the free cash flow to net income ratio is weak at 0.07, highlighting challenges in converting earnings into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.23B	3.15B	2.93B	2.61B	2.31B	2.09B
Gross Profit	2.62B	711.98M	682.61M	1.12B	979.89M	848.17M
EBITDA	498.63M	607.84M	189.11M	561.67M	459.47M	437.16M
Net Income	139.25M	255.61M	-21.67M	273.14M	190.63M	143.19M
Balance Sheet
Total Assets	6.31B	5.96B	5.36B	4.99B	4.77B	6.50B
Cash, Cash Equivalents and Short-Term Investments	131.42M	76.31M	100.07M	97.65M	133.81M	378.70M
Total Debt	2.39B	2.09B	1.51B	1.53B	1.64B	3.23B
Total Liabilities	3.08B	2.77B	2.47B	2.09B	2.19B	4.60B
Stockholders Equity	3.08B	3.07B	2.78B	2.81B	2.52B	1.90B
Cash Flow
Free Cash Flow	31.08M	-560.69M	38.21M	84.42M	129.67M	442.19M
Operating Cash Flow	424.81M	129.69M	462.34M	380.57M	374.48M	658.81M
Investing Cash Flow	-730.40M	-736.48M	-397.22M	-305.83M	1.02B	-281.84M
Financing Cash Flow	359.85M	583.02M	-62.70M	-110.90M	-1.64B	-51.50M

Acadia Healthcare Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 21.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACHC, the sentiment is Negative. The current price of 21.8 is below the 20-day moving average (MA) of 24.37, below the 50-day MA of 23.51, and below the 200-day MA of 26.83, indicating a bearish trend. The MACD of -0.33 indicates Positive momentum. The RSI at 35.16 is Neutral, neither overbought nor oversold. The STOCH value of 14.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ACHC.

Acadia Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SEM	―	$1.76B	13.38	8.15%	1.79%	-16.10%	-48.97%
NHC	―	$1.87B	18.19	10.65%	2.05%	25.19%	13.44%
ACHC	―	$2.01B	14.36	4.62%	―	5.64%	―
BKD	―	$2.20B	―	-108.91%	―	3.99%	-14.74%
SGRY	―	$2.84B	―	-9.75%	―	12.05%	-432.59%
LFST	―	$1.91B	―	-1.11%	―	13.86%	89.49%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Acadia Healthcare Corporate Events

Acadia Healthcare Appoints Todd Young as CFO

Acadia Healthcare Company, Inc. announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Young, who has previously held CFO roles at Elanco Animal Health and ACADIA Pharmaceuticals, will replace interim CFO Timothy Sides, who will return to his role as Senior Vice President, Operations Finance. The appointment is accompanied by a comprehensive employment agreement detailing Young’s compensation and benefits, including a substantial base salary, potential bonuses, and stock awards, reflecting the company’s commitment to strengthening its financial leadership.

The most recent analyst rating on (ACHC) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Acadia Healthcare stock, see the ACHC Stock Forecast page.

Acadia Healthcare Unveils 2026 Guidance at Jefferies Conference

Acadia Healthcare announced its participation in the Jefferies 2025 Healthcare Services Conference on September 29, 2025, where it provided preliminary guidance for 2026. The company expects a significant reduction in total capital expenditures by at least $300 million compared to 2025 and plans to add 500 to 700 beds in 2026. Additionally, Acadia reported a 1.3% growth in same facility patient days for the third quarter of 2025, indicating a positive trend in patient engagement. These developments suggest a strategic shift towards optimizing operational efficiency and expanding capacity, which could enhance Acadia’s market position and stakeholder value.

The most recent analyst rating on (ACHC) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Acadia Healthcare stock, see the ACHC Stock Forecast page.

Acadia Healthcare Reports Strong Q2 2025 Results

Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services in the United States, operating a network of facilities that offer a range of treatment options for mental health and substance use disorders.

Acadia Healthcare’s Earnings Call: Growth Amid Challenges

Acadia Healthcare’s recent earnings call presented a mixed sentiment, reflecting both positive strides and notable challenges. The company showcased its continued revenue growth and bed expansion efforts, alongside successful partnerships and quality initiatives. However, it also faced hurdles such as declining Medicaid volumes, underperforming facilities, and increased start-up costs, which tempered the overall positive outlook.